Evidence map›Paper›PMID 42251497›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Social vulnerability shapes deep clinical phenotypes and brain health in aging and dementia across Latin America.

Temitope Farombi, Tiago Azzi, Agustina Legaz, David Aguillón, José Alberto Avila-Funes, Maria Isabel Behrens, Martín Bruno, Juan Felipe Cardona, Nilton Custodio, Carolina Delgado and 27 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Temitope FarombiGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Tiago AzziDepartment of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Agustina LegazGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
David AguillónGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
José Alberto Avila-FunesDirección de Enseñanza, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Tlalpan, México.
Maria Isabel BehrensCentro de Investigación Clínica Avanzada (CICA), Hospital Clínico Universidad de Chile, Santiago, Chile.
Martín BrunoInstituto Ciencias Biomedicas (ICBM), Facultad Ciencias Medicas, Universidad Catolica de Cuyo, San Juan, Argentina.
Juan Felipe CardonaFacultad de Psicología, Universidad del Valle, Cali, Valle del Cauca, Colombia.
Nilton CustodioUnidad de Investigación de Deterioro Cognitivo y Prevención de Demencia, Instituto Peruano de Neurociencias, Lince, Peru.
Carolina DelgadoDepartamento de Neurociencia, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Stefanie Pina-EscuderoGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Maria Del Pilar Garavito GalofreFundación Universidad del Norte, Barranquilla, Atlántico, Colombia.
Marcelo MaitoCognitive Neuroscience Center (CNC), Universidad de San Andrés, Victoria, Buenos Aires, Argentina.
Nahuel Magrath-GuimetGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Justin B MillerDepartment of Neurology, University of Washington, Seattle, Washington, USA.
Diana MatallanaDepartamento de Salud Mental, Hospital Universitario Fundación Santa Fe, Bogotá, Colombia.
Maira Okada de OliveiraGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Guido RocattiCognitive Neuroscience Center (CNC), Universidad de San Andrés, Victoria, Buenos Aires, Argentina.
Elisa de Paula França ResendeGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Andrea SlachevskyDepartamento de Neurología y Psiquiatría, Clínica Alemana - Universidad del Desarrollo, Santiago, Chile.
Leonel TakadaCognitive Neurology and Behavioral Unit (GNCC), University of São Paulo, São Paulo, Brazil.
Olivia WenLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Peñalolén, Santiago, Chile.
Lina M Zapata-RestrepoGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Brian LawlorGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Kristine YaffeUCSF School of Medicine, University of California, San Francisco, San Francisco, California, USA.
Kun HuDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Bruce MillerGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Katherine PossinGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Jennifer S YokoyamaMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
Sol FittipaldiGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Adolfo M GarcíaGlobal Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
Hernan Hernandez LarzabalLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Peñalolén, Santiago, Chile.
Hernando Santamaria-GarciaCentro de Memoria y Cognición Intellectus, Hospital Universitario San Ignacio, Bogotá, Colombia.
Enzo TagliazzuchiLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Peñalolén, Santiago, Chile.
Claudia Duran-AniotzLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Peñalolén, Santiago, Chile.
Agustin IbanezGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Joaquin MigeotGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.

Funding

An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Integrative Motor Activity Biomarker for the Risk of Alzheimer's RiskRF1AG064312 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI HU, KUN · 2019 to 2019
$3.6M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Agencia Nacional de Promoción Científica y Tecnológica 01-PICTE-2022-05-00103ANID/FONDAP 15150012ANID/FONDECYT 1231839ANID/FONDECYT Regular 1210622ANID/FONDECYT Regular 1250091ANID/FONDECYT Regular 1250317ANID/FONDECYT Regular ANID/NAM22I0007ANID/PIA/ANILLOS ACT210096ANID/Proyecto Exploración 13240170Bluefield Project to Cure Frontotemporal DementiaBrightFocus Foundation Standard Award Program in Alzheimer's Disease Research A2026019SDavos Alzheimer's CollaborativeDICYT-USACH 032351G_DASFIC NIH HHSGlobal Brain Health Institute (GBHI)NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG083799NIA NIH HHS R01AG083799NIA NIH HHS RF1AG064312NIDA NIH HHS 75N95022C00031NIH-NIA R01AG057234ReDLatthe Alzheimer's Association 24AARG-D-1246942the Alzheimer's Association SG-21-715176-LATAM FINGERSthe Bluefield Project R01AG057234the Bluefield Project R56AG069118-01the Bluefield Project to Cure Frontotemporal Dementiathe National Institute on Aging 2P01AG019724the National Institute on Aging R01AG075775the National Institute on Aging R01AG083799the National Institutes of HealthWellcome Leap CARE Program CARE-2025-0883490149
6 · The paper itself

Abstract

introductionAdverse social conditions across the life course influence brain aging and dementia, yet their compounded impact on clinical phenotypes remains underexplored, particularly in Latin America, where social inequality and dementia burden are high.

methodsWe studied 3941 individuals from six Latin American countries, including cognitively unimpaired controls (CU), Alzheimer's disease (AD), and frontotemporal lobar degeneration (FTLD). A life-course questionnaire captured eight domains of social vulnerability, used to derive a social vulnerability index and latent vulnerability profiles. Brain health was characterized across 37 cognitive, functional, mental health, and dementia severity indicators.

resultsHigher vulnerability was mostly associated with executive and memory deficits in CU, cognitive and functional impairment in AD, and social cognition and neuropsychiatric symptoms in FTLD. Multidimensional brain health was affected across groups. DISCUSSION: Compounded social vulnerability is a key determinant of clinical expression in aging and dementia, underscoring the need for life-course-informed and equity-oriented dementia models.

Indexed as

AgingAlzheimer DiseaseBrainDementiaFrontotemporal Lobar DegenerationSocial VulnerabilityAgedAged, 80 and overFemaleHumansLatin AmericaMaleMiddle AgedNeuropsychological TestsPhenotypeSocioeconomic Disparities in Healthbrain healthglobal southLatin Americasocial determinants of healthsocial vulnerability

Identifiers

PMID42251497
PMCPMC13242611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.